Natco Pharma Ltd.
BSE: 524816 | NSE: NATCOPHARM
Small Cap | Pharmaceuticals & Drugs
923.65
5.75
(0.63%)
< Home
< Back
Natco Pharma Ltd. News
>>
Natco Pharma declines on preferential share allotment at discount
>>
Natco Pharma informs about demise of Director
>>
Natco Pharma soars as its US marketing partner receives USFDA approval for Armodafinil Tablets
>>
Natco’s US marketing partner receives USFDA approval for Armodafinil Tablets
>>
USFDA recognizes Natco Pharma’s Kothur Formulation Facility as acceptable
>>
Natco Pharma spurts as US marketing partner files ANDA for Everolimus Tablets
>>
Natco’s US marketing partner files ANDA for Everolimus Tablets
>>
Natco’s US marketing partner files ANDA for ‘Copaxone’
>>
Natco Pharma Fixes Book Closure for AGM
>>
Natco Pharma informs about Financial Results
<<
<
46
47
48
...52
>
>>